{"name": "Biocartis",
 "permalink": "biocartis",
 "crunchbase_url": "http://www.crunchbase.com/company/biocartis",
 "homepage_url": "http://www.biocartis.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2007,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "+41 21 693 90 51",
 "description": "",
 "created_at": "Fri Jul 09 04:39:32 UTC 2010",
 "updated_at": "Sat Mar 30 17:13:56 UTC 2013",
 "overview": "\u003Cp\u003EBiocartis SA, a molecular diagnostics company, develops diagnostics technology platform for multiplexed detection of bio-analytes. It focuses on integrated molecular and immunodiagnostics based on its proprietary micro-technology platform. The company develops and licenses a series of technologies to build a diagnostics platform for multiplexed detection, quantification, and amplification of bio-analytes, including proteins, nucleic acids, and small molecules. Its products are used for various applications, including analysis of bio-molecules associated with risks factors, early detection, staging, treatment selection, and monitoring of a disease. Biocartis SA was founded in 2007 and is based in Lausanne, Switzerland.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       44],
      "assets/images/resized/0017/3531/173531v1-max-150x150.png"],
     [[176,
       52],
      "assets/images/resized/0017/3531/173531v1-max-250x250.png"],
     [[176,
       52],
      "assets/images/resized/0017/3531/173531v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Executive director and CEO",
    "person":
     {"first_name": "Greg",
      "last_name": "Parekh",
      "permalink": "greg-parekh",
      "image": null}},
   {"is_past": false,
    "title": "Founder and Executive chairman",
    "person":
     {"first_name": "Rudi",
      "last_name": "Pauwels",
      "permalink": "rudi-pauwels-2",
      "image": null}},
   {"is_past": false,
    "title": "Co-Founder and CTO",
    "person":
     {"first_name": "Nader",
      "last_name": "Donzel",
      "permalink": "nader-donzel",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Hilde",
      "last_name": "Windels",
      "permalink": "hilde-windels",
      "image": null}},
   {"is_past": true,
    "title": "CTO",
    "person":
     {"first_name": "Jose",
      "last_name": "Gil",
      "permalink": "jose-gil",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$112M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.biocartis.com/cms/index.php?page=news",
    "source_description": "Biocartis raises \u00e2\u201a\u00ac30 million in Series \u00e2\u20ac\u02dcB' financing round",
    "raised_amount": 41300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 8,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Aescap Venture",
         "permalink": "aescap-venture",
         "image":
          {"available_sizes":
            [[[150,
               100],
              "assets/images/resized/0004/9289/49289v3-max-150x150.png"],
             [[157,
               105],
              "assets/images/resized/0004/9289/49289v3-max-250x250.png"],
             [[157,
               105],
              "assets/images/resized/0004/9289/49289v3-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company":
        {"name": "Debiopharm Group",
         "permalink": "debiopharm",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0011/1746/111746v1-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0011/1746/111746v1-max-250x250.png"],
             [[408,
               48],
              "assets/images/resized/0011/1746/111746v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development Corporation",
         "permalink": "johnson-johnson-development-corporation",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/8402/58402v1-max-150x150.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-250x250.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "KBC",
         "permalink": "kbc",
         "image":
          {"available_sizes":
            [[[109,
               104],
              "assets/images/resized/0005/9128/59128v1-max-150x150.jpg"],
             [[109,
               104],
              "assets/images/resized/0005/9128/59128v1-max-250x250.jpg"],
             [[109,
               104],
              "assets/images/resized/0005/9128/59128v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Advent Venture Partners",
         "permalink": "advent-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0001/6550/16550v3-max-150x150.png"],
             [[250,
               100],
              "assets/images/resized/0001/6550/16550v3-max-250x250.png"],
             [[450,
               181],
              "assets/images/resized/0001/6550/16550v3-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "c",
    "source_url": "http://www.finsmes.com/2011/11/biocartis-completes-e71m-series-equity-funding.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "Biocartis Completes \u00e2\u201a\u00ac71M Series C Equity Funding",
    "raised_amount": 71000000.0,
    "raised_currency_code": "EUR",
    "funded_year": 2011,
    "funded_month": 11,
    "funded_day": 17,
    "investments":
     [{"company":
        {"name": "Debiopharm Group",
         "permalink": "debiopharm",
         "image":
          {"available_sizes":
            [[[150,
               17],
              "assets/images/resized/0011/1746/111746v1-max-150x150.png"],
             [[250,
               29],
              "assets/images/resized/0011/1746/111746v1-max-250x250.png"],
             [[408,
               48],
              "assets/images/resized/0011/1746/111746v1-max-450x450.png"]],
           "attribution": null}},
       "financial_org": null,
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development Corporation",
         "permalink": "johnson-johnson-development-corporation",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/8402/58402v1-max-150x150.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-250x250.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Wellcome Trust",
         "permalink": "wellcome-trust",
         "image":
          {"available_sizes":
            [[[150,
               12],
              "assets/images/resized/0002/9701/29701v2-max-150x150.jpg"],
             [[250,
               20],
              "assets/images/resized/0002/9701/29701v2-max-250x250.jpg"],
             [[450,
               37],
              "assets/images/resized/0002/9701/29701v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "Scientific Parc EPFL, PSE-C",
    "address2": "",
    "zip_code": "CH-1015",
    "city": "Lausanne",
    "state_code": null,
    "country_code": "CHE",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}